Early amyloid accumulation in the hippocampus of SAMP8 mice

Journal of Alzheimer's Disease

Volumn 19, Issue 4, 2010, Pages 1303-1315

  Del Valle, Jaume ^a,b   Duran Vilaregut, Joaquim ^a,b   Manich, Gemma ^a   Casadesús, Gemma ^c   Smith, Mark A ^d   Camins, Antoni ^a,b   Pallàs, Mercè ^a,b   Pelegrí, Carme ^a,b   Vilaplana, Jordi ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Amyloid ; A 40; A 42; A PP; Hippocampus; SAMP8; SAMR1; Senescence

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; SENESCENCE ACCELERATED MOUSE;

EID: 77950366858     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1321     Document Type: Article

References (64)

1. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine. Z Psychiatrie Psychisch-Gerichtliche Med 64, 146-148.
2. Smith MA (1998) Alzheimer disease. Int Rev Neurobiol 42, 1-54.
3. Katzman R, Fox P (1999) The worldwide impact of dementia. Projections of prevalence and costs. In Epidemiology of Alzheimer's disease: from gene to prevention. Mayeux R, Christen Y, eds. Springer-Verlag, New York, pp. 1-17.
4. Avramopoulos D (2009) Genetics of Alzheimer's disease: recent advances. Genome Med 1, 34.
5. Newman M, Musgrave FI, Lardelli M (2007) Alzheimer disease: amyloidogenesis, the presenilins and animal models. Biochim Biophys Acta 1772, 285-297.
6. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9, 768-778.
7. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses AD,Williamson R, Rossor M, Owen MJ, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
8. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak- Vance M, Tanzi R, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
9. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
10. Gralle M, Ferreira ST (2007) Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 82, 11-32.
11. Kang J, Muller-Hill B (1990) Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4695 mRNAis predominantly produced in rat and human brain. Biochem Biophys Res Commun 166, 1192-1200.
12. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
13. Jarrett JT, Berger EP, Lansbury PT (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
14. Haass C, Selkoe DJ (1993) Cellular processing of -amyloid precursor protein and the genesis of amyloid -peptide. Cell 75, 1039-1042.
15. Selkoe DJ (1996) Cell biology of the β-amyloid precursor protein and the genetics of Alzheimer's disease. Cold Spring Harb Symp Quant Biol 61, 587-596.
16. Kojro E, Fahrenholz F (2005) The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem 38, 105-127.
17. Götz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9, 532-544.
18. Bryan KJ, Lee HG, Perry G, Smith MA, Casadesus G (2009) Transgenic mouse models of Alzheimer's disease: behavioral testing and considerations. In Methods of Behavioral Analysis in Neuroscience, Buccafusco JJ, ed. Taylor & Francis Group, Boca Raton, pp. 1-18.
19. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555.
20. Hamamoto H, Honma A, Irino M, Matsushita T, Toda K, Matsumura M, Takeda T (1984) Grading score system: A method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev 26, 91-102.
21. Takeda T, Hosokawa M, Higuchi K (1994) Senescenceaccelerated mouse (SAM), a novel murine model of aging. In The SAM model of senescence, Takeda T, ed. Elsevier, Amsterdam, pp. 15-22.
22. Takeda T (2009) Senescence-accelerated mouse (SAM) with special to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res 34, 639-659.
23. Miyamoto M (1997) Characteristics of age-related behavioural changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 32, 139-148.
24. Yagi H, Irino M, Matsushita T, Katoh S, Umezawa M, Tsuboyama T, Hosokawa M, Akiguchi I, Tokunaga R, Takeda T (1989) Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol 48, 577-590.
25. Kawamata T, Akiguchi I, Yagi H, Irino M, Sugiyama H, Akiyama H, Shimada A, Takemura M, Ueno M, Kitabayashi T, Ohnishi K, Seriu N, Higuchi K, Hosokawa M, Takeda T (1997) Neuropathological studies on strains of senescenceaccelerated mice (SAM) with age-related deficits in learning and memory. Exp Gerontol 32, 161-170.
26. Nomura Y, Okuma Y (1999) Age-related defects in lifespan and learning ability in SAMP8 mice. Neurobiol Aging 20, 111-115.
27. Spangler EL, Patel N, Speer D, Hyman M, Hengemihle J, Markowska A, Ingram DK (2002) Passive avoidance and complex maze learning in the senescence accelerated mouse (SAM): age and strain comparisons of SAM P8 and R1. J Gerontol A Biol Sci Med Sci 57, B61-B68.
28. Ueno M, Sakamoto H, Kanenishi K, Onodera M, Akiguchi I, Hosokawa M (2001) Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiol Aging 22, 469-478.
29. Pelegrí C, Canudas AM, del Valle J, Casadeśus G, Smith MA, Camins A, Pall̀as M,Vilaplana J (2007) Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev 128, 522-528.
30. Del Valle J, Duran-Vilaregut J, Manich G, Camins A, Pall̀as M, Vilaplana J, Pelegrí C (2009) Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice. Int J Dev Neurosci 27, 47-52.
31. Onozuka M, Watanabe K, Fujita M, Tomida M, Ozono S (2002) Changes in the septohippocampal cholinergic system following removal of molar teeth in the aged SAMP8 mouse. Behav Brain Res 133, 197-204.
32. Flood JF, Farr SA, Uezu K, Morley JE (1998) Age-related changes in septal serotonergic, GABAergic and glutamatergic facilitation of retention in SAMP8 mice. Mech Ageing Dev 105, 173-188.
33. Kondziella D, Bidar A, Urfjell B, Sletvold O, Sonnewald U (2002) The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: behavior and metabolism. Neurochem Int 40, 413-418.
34. Nomura Y, Kitamura Y, Ohnuki T, Arima Y, Yamanaka Y, Sasaki K, Oonuma Y(1997) Alterations in acetylcholine, NMDA, benzodiozepine receptors and protein kinase C in the brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhances. Behav Brain Res 83, 51-55.
35. Morley JE, Banks WA, Kumar VB, Farr SA (2004) The SAMP8 mouse as a model for Alzheimer disease: studies from Saint Louis University. Int Congr Ser 1260, 23-28.
36. Pall̀as M, Camins A, Smith MA, Perry G, Lee H, Casadesus G (2008) From aging to Alzheimer's disease: Unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 15, 615-624.
37. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, Flood JF (2000) β-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21, 1761-1767.
38. Takemura M, Nakamura S, Akiguchi I, Ueno M, Oka N, Ishikawa S, Shimada A, Kimura J, Takeda T (1993) A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol 142, 1887-1897.
39. Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y, Nomura Y (2000) Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse. Brain Res 885, 25-31.
40. Fukunari A, Kato A, Sakai Y, Yoshimoto T, Ishiura S, Suzuki K, Nakajima T (1994) CoIocalization of prolyl endopeptidase and amyloid P-peptide in brains of senescence-accelerated mouse. Neurosci Lett 176, 201-204.
41. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T (1981) A new murine model of accelerated senescence. Mech Ageing Dev 17, 183-194.
42. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Sterotaxic Coordinates. Academic Press, London.
43. Westermark P (2005) Aspects on human amyloid forms and their fibril polypeptides. FEBS J 272, 5942-5949.
44. Codita A, Winblad B, Mohammed AH (2006) Of mice and men: more neurobiology in dementia. Curr Opin Psychiatr 19, 555-563.
45. Morrissette D, Parachikova A, Green K, LaFerla F (2009) Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem 284, 6033-6037.
46. Tahara K, Kim H, Jin J, Maxwell JA, Li L, Fukuchi K (2006) Role of toll-like receptor signalling in Aβ uptake and clearance. Brain 129, 3006-3019.
47. Siedlak SL, Casadesus G,Webber KM, Pappolla MA, Atwood CS, Smith MA, Perry G (2009) Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic Res 43, 156-164.
48. Kato A, Fukunari A, Sakai Y, Nakajima T (1997) Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J Pharmacol Exp Ther 283, 328-335.
49. Güntert A, Döbeli H, Bohrmann B (2006) High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience 143, 461-475.
50. Yang F, Ueda K, Chen P, Ashe KH, Cole GM (2000) Plaqueassociated a-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res 853, 381-383.
51. Van Duinen SG, Maat-Schieman MLC, Bruijn JA, Haan J, Roos RAC (1995) Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (dutch) contains various extracellular matrix deposits. Lab Invest 73, 183-189.
52. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor α1- antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
53. Bramlett HM, Kraydieh S, Green EJ, Dietrich WD (1997) Temporal and regional patterns of axonal damage following traumatic brain injury: A beta-amyloid precursor protein immunocytochemical study in rats. J Neuropathol Exp Neurol 56, 1132-1141.
54. Justicia C, Ramos-Cabrer P, Hoehn M (2008) MRI detection of secondary damage after stroke: Chronic iron accumulation in the thalamus of the rat brain. Stroke 39, 1541-1547.
55. Arai H, Lee V, Otvos Jr L, Greenberg B, Lowery D, Sharma SK, Schmidt ML, Trojanowski JQ (1990) Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A 87, 2249-2253.
56. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
57. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reusberg B, Mlodzik B, de Leon MJ, Miller DC (1995) Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia 6, 205-210.
58. Bobinski M,Wegiel J, Tarnawski M, Bobinski M, Reisberg B, De Leon MJ, Miller DC,WisniewskiHM(1997) Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56, 414-420.
59. Rossler M, Zarski R, Bohl J, Ohm TG(2002) Stage-dependent and sector specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol 103, 363-369.
60. Kril JJ, Hodges J, Halliday G (2004) Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci Lett 361, 9-12.
61. Rosenzweig ES, Barnes CA (2003) Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 69, 143-179.
62. Jucker M, Ingram DK (1994) Age-related fibrillar material in mouse brain: Assessing its potential as a biomarker of aging and as a model of human neurodegenerative disease. Ann N Y Acad Sci 719, 238-247.
63. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen S, Aronson S (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13, 179-189.
64. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65, 1509-1517.